{
    "Case ID": "030220",
    "Crime_Name": [
        "Patent Infringement Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement"
    ],
    "Legal_Issue": [
        "Validity of patent for sildenafil's use in treating erectile dysfunction"
    ],
    "Governing_Law": [
        "Canadian patent law"
    ],
    "Procedural_Stage": [
        "Trial/Adjudication"
    ],
    "Evidence_Assessment": [
        "Prior art reviewed, expert testimony evaluated, commercial success considered"
    ],
    "Decision_Outcome": [
        "Patent upheld as valid"
    ],
    "Burden_of_Proof": [
        "On Apotex to prove invalidity"
    ],
    "Credibility_Factor": [
        "Expert opinions differed on obviousness; court credited Pfizer's evidence"
    ],
    "Legal_Rule": [
        "Patent valid if meets non-obviousness, novelty, and proper claim construction"
    ],
    "Standard_of_Review": [
        "Objective assessment under statutory patent requirements"
    ],
    "Procedural_Issue": [],
    "Grounds_for_Claim": [
        "Obviousness, anticipation, improper claim scope"
    ],
    "Outcome_on_Merits": [
        "In favor of Pfizer"
    ],
    "Decision_Maker": [
        "Federal Court"
    ],
    "Judicial_Review_Outcome": [],
    "Review_Standard": [],
    "Procedural_Fairness_Assessment": [],
    "Key_Evidence_Considered": [
        "Prior art, expert testimony, commercial success, lack of prior development"
    ],
    "Legal_Framework": [
        "Statutory patent requirements under Canadian law"
    ],
    "Applicant_Challenge": [
        "Apotex challenged validity to market generic Viagra"
    ],
    "Court_Result": [
        "Pfizer's patent upheld; Apotex prohibited from marketing generic until expiry"
    ],
    "Legal_Rule_Source": [
        "Canadian Patent Act"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Argued patent was obvious and anticipated by prior art"
    ],
    "Evidence_Type": [
        "Documentary evidence, expert evidence"
    ],
    "Remedy_Requested": [
        "Declaration of patent invalidity, right to market generic"
    ],
    "Outcome": [
        "Patent found valid, infringement prevented"
    ],
    "Decision_Authority": [
        "Federal Court of Canada"
    ],
    "Remedy_Sought": [
        "Market entry for generic sildenafil"
    ],
    "Resolution_Mechanism": [
        "Litigation"
    ],
    "Legal_Provision": [
        "Patent Act, sections on novelty, non-obviousness, utility"
    ],
    "Authority": [
        "Federal Court"
    ],
    "Claimant_Status": [
        "Apotex as challenger, Pfizer as patent holder"
    ],
    "Legal_Provision_Cited": [
        "Relevant provisions of the Canadian Patent Act regarding patentability"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Obviousness, anticipation, overbroad claims"
    ],
    "Applicable_Process": [
        "Judicial proceeding under federal patent law"
    ],
    "Outcome_of_Review": [],
    "Pending_Relief_or_Application": [],
    "Jurisdiction": [
        "Canada, Federal Court"
    ],
    "Governing_Rule": [
        "Non-obviousness, novelty, and claim construction standards"
    ]
}